Virginia Commonwealth University;Enzo Therapeutics, Inc.
发明人:
Sarah Spiegel,Robert Elliot Zipkin,Jeffrey Kroll Adams
申请号：
US16813961
公开号：
US20200197328A1
申请日:
2020.03.10
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Provided are inhibitors of sphingosine kinase Type I that are useful in a number of applications, indications and diseases, as well as for monitoring pharmacokinetics and patient management. These compounds are applicable to treating ischemic diseases such as myocardial infarction and stroke.
